Rapid access for research on coronavirus SARS-CoV-2

Researchers worldwide are trying to develop drugs or a vaccine against the coronavirus SARS-CoV-2. In view of the corona pandemic, the Heinz Maier-Leibnitz Zentrum (MLZ) also offers special access to measurements with neutrons, which can provide important insights into the behaviour of the virus.

Illustration of SARS-CoV-2. (© CDC/ Alissa Eckert, MS; Dan Higgins, MAMS)

Scientists who want to use neutrons to study the corona virus SARS-CoV-2 or the disease COVID-19 will have special and privileged access. They do not have to apply for measurement time through the usual channels. "Research on the coronavirus SARS-CoV-2 and on the disease COVID-19 currently has priority over all other applications for measurement time at the MLZ," said Prof. Dr. Peter Müller-Buschbaum, Scientific Director of the FRMII. That is why the MLZ has set up a rapid access for research on the coronavirus SARS-CoV-2 with immediate effect. Guest scientists should contact the user office directly with their applications for measurement time. A scientific evaluation of the application will then take place as soon as possible.